Using virtual reality to improve arm and hand function after subacute stroke
Official title: The Effect of Virtual Reality Therapy on Upper Extremity Functions in Subacute Stroke Patients Receiving Conventional Rehabilitation and Action Observation Therapy: A Randomized Controlled Single-Blind Study
Run by Istanbul Physical Medicine Rehabilitation Training and Research Hospital · NCT07299162 · Data updated 2026-11-12
This study will try adding virtual reality sessions to standard rehabilitation and action observation therapy to see if people in the subacute phase of stroke can regain better arm and hand movement.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 38 (estimated) |
| Sponsor | Istanbul Physical Medicine Rehabilitation Training and Research Hospital Government |
| Locations | 1 site (Istanbul, Bahçelievler) |
| Status | Recruiting |
| Started | August 15, 2025 |
| Main results expected | March 25, 2026 |
| Study ends | April 20, 2026 |
| Registry record updated | January 28, 2026 |
| Trial ID | NCT07299162 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) in the subacute phase of a first-ever stroke (6 weeks to 6 months), with Brunnstrom stage ≥3 for the affected upper extremity/hand and MMSE ≥20, are ideal candidates.
✕Probably not a fit
Patients with severe paretic shoulder pain, bilateral stroke, global aphasia or major cognitive impairment, severe visual deficits, unilateral spatial neglect, inability to sit, or very high arm spasticity (Modified Ashworth Scale >4) are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with a first-ever subacute stroke (6 weeks to 6 months) are randomly assigned to two groups that both receive conventional rehabilitation plus action observation therapy, with one group also receiving additional virtual reality therapy. Treatments are delivered frequently (conventional therapy 5 days per week; action observation therapy 3 times per week) and virtual reality is given alongside these programs for the experimental arm. Participants are evaluated before treatment using standardized measures of upper extremity motor function, functional tasks, impairment scales, and a patient-reported impact scale, and outcomes are compared between groups. The randomized design and repeated standardized assessments are intended to determine whether adding virtual reality produces greater improvement than conventional care plus action observation alone.
Why it matters
Potential benefit: If successful, adding virtual reality could improve arm and hand function and make daily activities easier for people recovering from subacute stroke.
How similar studies have gone: Previous smaller trials of virtual reality and of action observation therapy have reported modest improvements in upper-limb function, but results are mixed and combining these approaches is not yet definitively proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients over the age of 18 * Patients in the subacute phase of stroke (between 6 weeks and 6 months post-stroke) * Patients with a first-ever stroke * Brunnstrom stage 3 or above for both upper extremity and hand * Mini-Mental State Examination (MMSE) score \>=20 No major medical condition that would prevent participation in the treatment Exclusion Criteria: * Presence of pain in the paretic shoulder severe enough to prevent exercise * History of bilateral stroke * Patients with global aphasia and/or cognitive impairment that significantly affects treatment compliance * Patients with severe visual impairment * Presence of unilateral spatial neglect * Inability to maintain sitting balance * Modified Ashworth Scale \> 4 in the hemiplegic arm
Where it's running
-
Istanbul Physical Therapy and Rehabilitation Training and Research Hospital
Istanbul, Bahçelievler, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Seda Akbayrak, MD — Istanbul Physical Therapy and Rehabilitation Training and Research Hospital
- Study coordinator: Seda Akbayrak, MD
- Email: akbayrakseda@gmail.com
- Phone: +90 5312478829
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PEARL: Rehabilitation and recovery after atrial fibrillation-related ischemic stroke
This project will see if adults with atrial fibrillation-related ischemic stroke have different rehabilitation needs and whether higher-intensity inpatient therapy (3–5 sessions/day) leads to better functional recovery at six months than moderate-intensity care (1 session/day).
-
Psilocybin to reopen brain plasticity after chronic stroke
This trial will test whether a supervised dose of psilocybin is safe and can help reopen brain plasticity in adults who had an ischemic or hemorrhagic stroke at least 12 months ago.
-
Deep phenotyping to explore recovery in young adults after stroke
This project will test whether a detailed health and sample-collection approach (deep phenotyping) is practical and acceptable for people aged 18–55 who have had a stroke.
-
Stem cell therapy for chronic stroke recovery
This study is testing whether using a patient's own stem cells can help people with long-term stroke recovery feel better and improve their daily functioning.
-
AI-based tools to help diagnose, treat and predict stroke outcomes across multiple hospitals
This study tests AI-powered tools on real-world stroke patients to see if they can improve pre-hospital triage, diagnosis, and outcome prediction while data stay securely within each hospital.
-
Web-based therapy using action observation and mirror therapy for arm weakness after stroke
This trial tests whether a mobile telerehabilitation app delivering action observation therapy (AOT) alone or combined AOT with mirror therapy (AOT-MT) can improve upper limb function in people with subacute stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.